Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
32.19 (USD) • At close January 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -352.088 | -231.801 | -356.51 | -327.37 | -411.472 | -346.028 | -314.67 | -198.471 | -117.732 | -53.504 | -39.407 | -20.102 | -23.706 |
| Depreciation & Amortization
| 6.623 | 8.564 | 9.24 | 9.984 | 8.087 | 7.172 | 6.432 | 5.708 | 3.342 | 1.367 | 1.44 | 1.179 | 0.801 |
| Deferred Income Tax
| 0 | 0 | -86.273 | 3.022 | -2.143 | 0 | 0 | 0 | 0 | 0 | 3.842 | 6.707 | -10.66 |
| Stock Based Compensation
| 44.766 | 49.296 | 53.508 | 61.602 | 72.373 | 73.357 | 47.809 | 42.086 | 31.963 | 11.506 | 3.03 | 0.742 | 0.371 |
| Change In Working Capital
| -19.057 | -16.433 | -36.822 | -71.037 | -45.999 | -35.105 | -24.832 | 188.466 | 4.906 | -19.26 | -25.589 | -38.371 | 17.584 |
| Accounts Receivables
| -0.604 | -2.206 | -4.378 | -10.06 | -3.619 | -6.102 | 1.216 | 3.339 | -1.733 | -6.016 | -0.476 | 0 | 0 |
| Inventory
| -10.584 | -8.492 | 4.378 | -7.367 | -6.462 | -0.869 | -2.078 | 14.434 | -3.175 | 0.019 | 0 | 0 | 0 |
| Accounts Payables
| -8.733 | 3.436 | 1.863 | 5.889 | 3.716 | -5.488 | 5.329 | 3.501 | 4.215 | 7.577 | 0.03 | -0.322 | 0.809 |
| Other Working Capital
| 0.864 | -9.171 | -38.685 | -59.499 | -39.634 | -22.646 | -29.299 | 167.192 | 5.599 | -20.84 | -25.619 | -38.049 | 16.775 |
| Other Non Cash Items
| 23.694 | -119.104 | 9.537 | 19.52 | 8.532 | -3.817 | 0.029 | 0.773 | 0.572 | 0.538 | 0.284 | 0.297 | 0.391 |
| Operating Cash Flow
| -296.062 | -309.478 | -407.32 | -290.759 | -370.622 | -304.421 | -285.232 | 38.562 | -76.949 | -59.353 | -56.4 | -49.548 | -15.219 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -0.999 | -4.881 | -5.741 | -14.909 | -12.171 | -6.986 | -4.627 | -9.915 | -20.164 | -2.216 | -1.294 | -1.475 | -1.906 |
| Acquisitions Net
| 0 | 132.748 | 0 | 0.803 | -103.468 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -417.93 | -1,030.781 | -1,378.221 | -557.03 | -488.566 | -933.32 | -688.702 | -506.067 | -353.177 | -837.219 | -146.049 | -88.524 | -105.936 |
| Sales Maturities Of Investments
| 674.679 | 1,146.175 | 829.804 | 647.685 | 592.177 | 666.481 | 635.421 | 396.632 | 501.65 | 505.528 | 60.126 | 113.041 | 85.482 |
| Other Investing Activites
| -16.175 | 0 | 1,802.936 | -0.803 | 103.468 | -266.839 | -53.281 | -109.435 | 148.473 | 0.571 | -85.923 | 24.517 | 0 |
| Investing Cash Flow
| 239.575 | 243.261 | 1,248.778 | 75.746 | 91.44 | -273.825 | -57.908 | -119.35 | 128.309 | -333.336 | -87.217 | 23.042 | -22.36 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | -0.331 | -0.578 | -0.336 | -0.113 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 5.433 | 2.681 | 0 | 11.317 | 277.201 | 516.206 | 270.25 | 162.15 | 6.373 | 333.577 | 126.117 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | -802.486 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 5.433 | 2.681 | 37.296 | 261.854 | 12.523 | 29.818 | 14.86 | 7.628 | 6.373 | 1.583 | -2.237 | 0.142 | 77.358 |
| Financing Cash Flow
| 5.433 | 2.35 | -765.768 | 261.518 | 289.611 | 546.024 | 285.11 | 169.778 | 6.373 | 335.16 | 123.88 | 0.142 | 77.358 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -51.054 | -63.867 | 75.69 | 46.505 | 10.429 | -32.222 | -58.03 | 88.99 | 57.733 | -57.529 | -19.737 | -26.364 | 39.779 |
| Cash At End Of Period
| 88.205 | 139.259 | 203.126 | 127.436 | 80.931 | 70.502 | 102.724 | 160.754 | 71.764 | 14.031 | 71.56 | 91.297 | 117.661 |